Sym004, a novel anti-EGFR antibody mixture augments radiation response in human lung and head and neck cancer models

被引：0
|
作者：
Huang, Shyhmin [1 ]
Armstrong, Eric A. [1 ]
Kragh, Michael [2 ]
Pedersen, Mikkel W. [2 ]
Harari, Paul M. [1 ]
机构：
[1] Univ Wisconsin, Madison, WI USA
[2] Symphogen AS, Lyngby, Denmark
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-2720
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2720
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Sym004, a Novel Anti-EGFR Antibody Mixture, Augments Radiation Response in Human Lung and Head and Neck Cancers
    Huang, Shyhmin
    Peet, Chimera R.
    Saker, Jarob
    Li, Chunrong
    Armstrong, Eric A.
    Kragh, Michael
    Pedersen, Mikkel W.
    Harari, Paul M.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (12) : 2772 - 2781
  • [2] Sym004: A novel synergistic anti-EGFR antibody mixture with superior anti-cancer efficacy
    Dienstmann, R.
    Patnaik, A.
    Tolcher, A. W.
    Pedersen, M. W.
    Jacobsen, H. J.
    Kofoed, K.
    Petersen, J.
    Tabernero, J.
    Kragh, M.
    ANNALS OF ONCOLOGY, 2011, 22 : 22 - 22
  • [3] A proof of concept trial of the anti-EGFR antibody mixture Sym004 in patients with squamous cell carcinoma of the head and neck
    J.-P. Machiels
    P. Specenier
    J. Krauß
    A. Dietz
    M.-C. Kaminsky
    Y. Lalami
    M. Henke
    U. Keilholz
    R. Knecht
    N. J. Skartved
    I. D. Horak
    P. Pamperin
    S. Braun
    T. C. Gauler
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 13 - 20
  • [4] A proof of concept trial of the anti-EGFR antibody mixture Sym004 in patients with squamous cell carcinoma of the head and neck
    Machiels, J. -P.
    Specenier, P.
    Krauss, J.
    Dietz, A.
    Kaminsky, M. -C.
    Lalami, Y.
    Henke, M.
    Keilholz, U.
    Knecht, R.
    Skartved, N. J.
    Horak, I. D.
    Pamperin, P.
    Braun, S.
    Gauler, T. C.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (01) : 13 - 20
  • [5] The anti-EGFR antibody mixture Sym004 overcomes acquired resistance to cetuximab in colorectal cancer
    Sanchez-Martin, Francisco J.
    Dalmases, Alba
    Bellosillo, Beatriz
    Argiles, Guillem
    Gelabert, Mariona
    Canadas, Israel
    Vidal, Joana
    Siravegna, Giulia
    Arena, Sabrina
    Koefoed, Klaus
    Visa, Laura
    Arpf, Oriol
    Horak, Ivan D.
    Iglesias, Mar
    Stroh, Christopher
    Kragh, Michael
    Rovira, Ana
    Albanell, Joan
    Bardelli, Alberto
    Tabernero, Josep
    Montagut, Clara
    CANCER RESEARCH, 2016, 76
  • [6] Efficacy of Sym004, a novel anti-EGFR antibody mixture, against EGFRvIII positive glioblastoma xenografts.
    Keir, Stephen T.
    Roskoski, Martin A.
    Kragh, Michael
    Pederson, Mikkel W.
    Jacobsen, Helle J.
    Horak, Ivan D.
    Friedman, Henry S.
    Bigner, Darell D.
    CANCER RESEARCH, 2013, 73 (08)
  • [7] Preclinical efficacy of Sym004, novel anti-EGFR antibody mixture, in esophageal squamous cell carcinoma cell lines
    Fukuoka, Shota
    Kojima, Takashi
    Koga, Yoshikatsu
    Yamauchi, Mayumi
    Komatsu, Masayuki
    Komatsuzaki, Rie
    Sasaki, Hiroki
    Yasunaga, Masahiro
    Matsumura, Yasuhiro
    Doi, Toshihiko
    Ohtsu, Atsushi
    ONCOTARGET, 2017, 8 (07) : 11020 - 11029
  • [8] The role of Sym004, a novel EGFR antibody mixture, in patients with refractory colorectal cancer
    Fountzilas, Elena
    Pentheroudakis, George
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S87 - S90
  • [9] Safety and Activity of the First-in-Class Sym004 Anti-EGFR Antibody Mixture in Patients with Refractory Colorectal Cancer
    Dienstmann, Rodrigo
    Patnaik, Amita
    Garcia-Carbonero, Rocio
    Cervantes, Andres
    Benavent, Marta
    Rosello, Susana
    Tops, Bastiaan B. J.
    van der Post, Rachel S.
    Argiles, Guillem
    Skartved, Niels J. O.
    Hansen, Ulla H.
    Hald, Rikke
    Pedersen, Mikkel W.
    Kragh, Michael
    Horak, Ivan D.
    Braun, Stephan
    Van Cutsem, Eric
    Tolcher, Anthony W.
    Tabernero, Josep
    CANCER DISCOVERY, 2015, 5 (06) : 598 - 609
  • [10] Sym004, a novel strategy to target EGFR with an antibody mixture, in patients with advanced SCCHN progressing after anti-EGFR monoclonal antibody: A proof of concept study
    Machiels, Jean-Pascal H.
    Specenier, Pol M.
    Krauss, Juergen
    Dietz, Andreas
    Kaminsky, Marie-Christine
    Lalami, Yassine
    Henke, Michael
    Keilholz, Ulrich
    Knecht, Rainald
    Skartved, Niels Jorgen Ostergaard
    Horak, Ivan David
    Flensburg, Mimi F.
    Gauler, Thomas Christoph
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345